BIODESIX, INC. BDSX 深 滬
等待開盤 10-27 09:30:00 美东时间
6.73
+0.300
+4.67%
華盛通- 最 高6.96
- 今 開6.50
- 成交量 10.06万股
- 最 低 6.2227
- 昨 收 6.43
- 總市值 5249.40万
- 52周最高 32.20
- 市盈率 靜 --
- 換手率 1.29%
- 52周最低 3.436
- 委 比 66.67%
- 總股本 780.00万
- 歷史最高 639.80
- 量 比 0.10
- 振 幅 11.47%
- 歷史最低 3.436
- 每 手 1
- 風險率 8.58%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays
<p>Biodesix announced an expanded partnership with Bio-Rad to develop and validate in vitro diagnostic assays using ddPCR technology for detecting genomic markers in oncology, starting with the ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer. The assay will enable sensitive detection of ESR1 mutations in ctDNA, aiding the development of targeted therapies and monitoring cancer treatment. Biodesix will manufacture and distribute sp...
10-22 10:17
Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting
Biodesix will present preliminary data from the first 1,000 patients enrolled in the CLARIFY study at the 2025 CHEST Annual Meeting. The study evaluates the performance of Nodify Lung tests in real-world clinical settings, aiming to improve lung nodule management. Additional presentations will highlight the impact of these tests on healthcare resource utilization and patient outcomes. Biodesix leaders will also discuss future biomarker developmen...
10-15 10:09
Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit
Biodesix, a diagnostics solutions company, partners with three Colorado-based lung health organizations to host three events in October for healthcare professionals and patients. The events include a lung nodule education seminar by APAPP, a Lung Cancer Centers of Excellence Summit organized by the Go2 Association, and the American Lung Association's "Run the Rocks" fundraiser. These initiatives aim to promote lung health awareness and education,...
10-06 14:13
Biodesix Regains Nasdaq Compliance with Bid Price
The latest update is out from Biodesix ( ($BDSX) ). On September 26, 2025, Biod...
10-02 04:35
美股大行评级 | 潜在涨幅302.68%！Maxim Group上调T Stamp目标价至12美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持T Stamp"买入"评级，目标价从8美元升至12美元；Maxim Group：维持Rezolute"买入"评级，目标价从15美元升至20美元
09-22 18:44
Canaccord Genuity Maintains Buy on Biodesix, Lowers Price Target to $20
Canaccord Genuity analyst Kyle Mikson maintains Biodesix (NASDAQ:BDSX) with a Buy and lowers the price target from $30 to $20.
09-20 00:48
Biodesix Analyst Ratings
Unity Software(U.US) reported fourth-quarter financial results after the market...
09-20 00:47
Biodesix announces one-for-twenty reverse stock split
Biodesix (NASDAQ:BDSX) on Thursday announced a one-for-twenty reverse stock split of the company’s common stock, par value $0.001, which will become effective on September 15, 2025. The company’s comm...
09-11 20:32
Biodesix shares are trading lower after the company announced a 1-for-20 reverse stock split.
Biodesix shares are trading lower after the company announced a 1-for-20 revers...
09-11 20:09
Biodesix to Participate in Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference
Biodesix, Inc. announces that Robin Cowie, Chief Financial Officer, will host in-person 1x1 investor meetings at Lake Street Capital Markets' Annual Best Ideas Growth (BIG9) Conference on September 11, 2025, in New York. Biodesix is a leading diagnostic solutions company focused on improving clinical care and outcomes for patients with lung disease through its diagnostic tests and development services.
09-05 10:00
